Drugs of Abuse Arrays by Randox Laboratories Ltd.

As drug misuse increases and new drugs continually enter the market, Randox Toxicology has responded by developing innovative solutions for fast and accurate forensic drug screening. Biochip Array Technology has become a prevalent screening method providing advancement on traditional ELISA principles. A range of multiplex testing platforms are available to suit a variety of settings from the emergency room to the mortuary.

Drugs of Abuse Array I Plus
Amphetamine
Barbiturates
Benzodiazepine 1
Benzodiazepine 2
Cannabinoids
Cocaine metabolite (Benzoylecgonine)
MDMA
Methadone
Methamphetamine
Opiates
Phencyclidine
Tricyclic Antidepressants (TCAs Generic)
Creatinine*
Drugs of Abuse Array II
Buprenorphine
Fentanyl
Generic Opioids
Ketamine
LSD
MDMA
Methaqualone
Oxycodone 1
Oxycodone 2
Propoxyphene
Creatinine*
Drugs of Abuse Array III
Chloral Hydrate Metabolite
Ethyl Glucuronide
Fentanyl
Ketamine Metabolite
Meperidine
Meprobamate
Zaleplon
Zolpidem
Zopiclone
7-amino Flunitrazepam
Creatinine*

Drugs of Abuse Array IV
Acetaminophen
Dextromethorphan
Escitalopram
Fluoxetine
Haloperidol
Ibuprofen
Methylphenidate
Salicylate
Salicyluric acid
Sertraline
Tramadol
Trazodone
Tricyclic Antidepressants (TCAs Generic)
Creatinine*
Drugs of Abuse Array V
Benzylpiperazines
MDPV
Mephedrone
Mescaline
Phenylpiperazines
Salvinorin
Synthetic Cannabinoids
Creatinine*
*Creatinine is included as a marker of dilution for urine

Key Benefits of the Drugs of Abuse Arrays
• Simultaneous screening – consolidation offers a one-shot drug screen profile
• Reduced turnaround time – up to 13 times faster than ELISA
• Reduced costs – improve laboratory efficiency • Multiple forensic matrices – one flexible system for all testing requirements
• Diagnostic quality results – improves laboratory efficiency
• Optimisation in a range of forensic matrices – reduces false results
• Small sample volume – allowing more for confirmatory analysis
• Reduced sample preparation – further time and labour saving
• Reduction in false results – increasing laboratory workflow
• Excellent specificity – ensuring accurate results
• Excellent correlation with confirmatory methods – minimising un-necessary tests
• Built in adulteration check – provides confidence in results
• Best Practice principles – meeting accreditation requirements
• Dual applications for batch or STAT analysis – flexibility to suit your requirements
• Applications for onsite rapid testing – to meet the growing demand for near-patient screening